Project leads
Collaborators

Prospective Study of Serum MIS and Gynecologic Cancer Risk

Joanne F Dorgan

5 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Follow

Collaborator from New York University

New York University

New York, United States

Vittorio Krogh

Cairo University

Giza, Egypt

Istituto Nazionale dei Tumori (IRCCS)

Milan, Italy

Theron Johnson

German Cancer Research Center (HZ)

Heidelberg, Germany

Naomi Allen

University of Oxford

Oxford, United Kingdom

Annika Idahl

Umeå University

Umeå, Sweden

Joanne F Dorgan

University of Maryland, Baltimore

Baltimore, United States

Related projects

Andre Michael Lieber

Evaluation of Vectors Based on Group B Adenoviruses

Linda S Cook

Mitochondrial DNA and Ovarian Cancer Risk and Survival

Global Noncommunicable Diseases Intiatives

Diagnosis and premature treatments against the uterine carcinoma

Norman Wolmark

NRG Oncology Network Group Operations Center

Ovary Corpus uteri

Surgery / Surgical oncology Radiation Oncology

Scott H Kaufmann

Mayo Clinic SPORE in Ovarian Cancer

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Corpus uteri Ovary

Garnet L. Anderson

Womens Health Initiative Cancer Survivor Cohort

Malcolm C Pike

Hormonal effects on fallopian tube and ovary inclusion cysts, and ovarian cancer

Sandra Orsulic

(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women